The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery
- 1 June 1989
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 23 (3) , 365-371
- https://doi.org/10.1016/0167-5273(89)90197-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dopexamine hydrochloride, a β2 adrenergic and dopaminergic agonist; haemodynamic effects following cardiac surgeryEuropean Heart Journal, 1988
- Beneficial Haemodynamic Effects of Intravenous Dopexamine in Patients with Low-Output Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Pro: Strong inotropes (ie, epinephrine) should be drugs of first choice during emergence from cardiopulmonary bypassJournal of Cardiothoracic Anesthesia, 1987
- Acute Hemodynamic and Neuroendocrine Effects of Dopexamine, a New Vasodilator for the Treatment of Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptorsEuropean Journal of Clinical Pharmacology, 1987
- Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failureEuropean Heart Journal, 1986
- The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.British Journal of Clinical Pharmacology, 1986
- Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.Heart, 1985
- The effects of dopexamine on the cardiovascular system of the dogBritish Journal of Pharmacology, 1985
- Dopexamine: a novel agonist at peripheral dopamine receptors and β2‐adrenoceptorsBritish Journal of Pharmacology, 1985